galantamine has been researched along with Bradyarrhythmia in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Citerne, O; Genuit-Leclerc, L; Leclerc, C | 1 |
| Cantor, MD; Farwell, W; Hernandez, RK; Lawler, EV | 1 |
| Bozoglu, E; Isik, AT; Kilic, S; Naharci, MI | 1 |
| STOJANOV, EA | 1 |
| Herrmann, N; Lanctôt, KL; Thompson, S | 1 |
| Erkova, AI; Savateev, NV; Sherstobitov, OE; Sofronov, GA | 1 |
1 review(s) available for galantamine and Bradyarrhythmia
| Article | Year |
|---|---|
The benefits and risks associated with cholinesterase inhibitor therapy in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Animals; Basal Ganglia Diseases; Bradycardia; Central Nervous System Diseases; Cholinesterase Inhibitors; Clinical Trials as Topic; Comorbidity; Donepezil; Double-Blind Method; Drug Evaluation; Drug Interactions; Female; Galantamine; Gastrointestinal Diseases; Humans; Indans; Institutionalization; Longitudinal Studies; Male; Memantine; Meta-Analysis as Topic; Mice; Middle Aged; Nootropic Agents; Phenylcarbamates; Piperidines; Randomized Controlled Trials as Topic; Rivastigmine; Single-Blind Method; Sleep Wake Disorders; Treatment Outcome | 2004 |
1 trial(s) available for galantamine and Bradyarrhythmia
| Article | Year |
|---|---|
Evaluation of the effects of galantamine on cardiac function in elderly patients with Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Blood Pressure; Bradycardia; Cholinesterase Inhibitors; Delayed-Action Preparations; Diagnostic and Statistical Manual of Mental Disorders; Dose-Response Relationship, Drug; Female; Galantamine; Heart Block; Humans; Male; Nootropic Agents; Patient Dropouts | 2010 |
5 other study(ies) available for galantamine and Bradyarrhythmia
| Article | Year |
|---|---|
[Bradycardia induced by galantamine].
Topics: Aged, 80 and over; Bradycardia; Cholinesterase Inhibitors; Galantamine; Humans; Male | 2008 |
Cholinesterase inhibitors and incidence of bradycardia in patients with dementia in the veterans affairs new England healthcare system.
Topics: Alzheimer Disease; Bradycardia; Cholinesterase Inhibitors; Cross-Sectional Studies; Dementia; Donepezil; Dose-Response Relationship, Drug; Drug Therapy, Combination; Galantamine; Heart Rate; Hospitals, Veterans; Humans; Incidence; Indans; Massachusetts; Nootropic Agents; Phenylcarbamates; Piperidines; Risk; Rivastigmine; Veterans | 2009 |
Bradycardia due to cholinesterase inhibitors: identify adverse effects and take them into account.
Topics: Alzheimer Disease; Bradycardia; Cholinesterase Inhibitors; Donepezil; Galantamine; Humans; Indans; Phenylcarbamates; Piperidines; Risk; Rivastigmine | 2011 |
[GALANTHAMINUM HYDROBROMICUM ("NIVALINE"), A NEW ANTIDOTE OF NON-POLARIZING MUSCLE RELAXANTS. PHARMACOLOGY AND CLINICAL USE].
Topics: Anesthesia; Anesthesiology; Animals; Antidotes; Atropine; Biomedical Research; Bradycardia; Cats; Galantamine; Mice; Muscle Relaxants, Central; Neostigmine; Neuromuscular Nondepolarizing Agents; Pharmacology; Rabbits; Rats | 1964 |
[Some differences in the effects of anticholinesterase compounds on nicotine and arecoline sensitivity in mice and rabbits].
Topics: Animals; Bradycardia; Central Nervous System; Cholinesterase Inhibitors; Galantamine; Heart; Mice; Nicotine; Parasympathomimetics; Peripheral Nerves; Phosphates; Rabbits; Tremor | 1966 |